Screener
Artiva Biotherapeutics, Inc. ARTV Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $21.93M+22.8% | $19.31M+13.3% | $16.99M+27.6% | $17.63M+30.4% | $17.86M+44.8% | ||
| $4.97M+0.3% | $5.12M0.0% | $4.94M-0.2% | $5.26M+9.4% | $4.95M+28.3% | ||
| $26.89M+17.9% | $24.43M+10.2% | $21.93M+20.1% | $22.9M+24.9% | $22.81M+40.9% | ||
| -$26.89M-17.9% | -$24.43M-10.2% | -$21.93M-20.1% | -$22.9M-24.9% | -$22.81M-40.9% | ||
| $1.89M+21.1% | $914K-50.9% | $1.16M-46.6% | $1.37M+58.6% | $1.56M+194% | ||
| -$25.01M-17.6% | -$23.52M-15.8% | -$20.77M-29.1% | -$21.53M-23.2% | -$21.25M-19.1% | ||
| -$0.63+27.6% | -$0.95-14.5% | -$0.84— | -$0.88+4.3% | -$0.87+96.0% | ||
| -$26.2M-18.2% | -$23.76M-10.3% | -$21.27M-20.5% | -$22.24M-25.6% | -$22.17M-42.2% | ||
| -$26.89M-17.9% | -$24.43M-10.2% | -$21.93M-20.1% | -$22.9M-24.9% | -$22.81M-40.9% |
FAQ
- Is Artiva Biotherapeutics, Inc. profitable?
- Artiva Biotherapeutics, Inc. is not currently profitable: it reported a net loss of $90.8M over the trailing twelve months, a -79.3% net margin.
- What is Artiva Biotherapeutics, Inc.'s earnings per share?
- Artiva Biotherapeutics, Inc.'s diluted EPS over the trailing twelve months is $-3.30.
- Where does Artiva Biotherapeutics, Inc.'s income statement data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.